Because Siebel Innovation Pack (IP) 2016 was such a significant departure from previous Siebel versions, our clinical operations team devoted much of last year to beta testing it, helping Oracle identify and iron out the kinks. Now that we have finished our assessment of the risks and rewards of upgrading Siebel Clinical to IP2016, we are ready to share them with you.
This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
Watch the webinar here. Param Singh, director of clinical operations solutions, highlights not only the features and benefits of IP2016, but the risks involved in upgrading, including a look at computer system validation (CSV) and regulatory compliance issues.
We will also provide a sneak preview of IP2017, based on the insider information we receive as an Oracle Platinum Partner.